Eric Bradford, M.D. Named Chief Medical Officer of Areteia Therapeutics

Areteia Therapeutics announced the hire of Eric Bradford M.D. as Chief Medical Officer. Dr. Bradford joins Areteia after a 20+ year career in biopharma, working on early-stage research, clinical development, medical affairs, life cycle management and commercialization. He has extensive experience in asthma, respiratory diseases, as well as other therapeutic areas, spanning 18 years at GSK. During this time, he oversaw numerous global studies, and provided medical affairs and development leadership for the anti-IL5 mAB programs targeting severe asthma.

Dr. Bradford joins the executive leadership team with responsibility for overseeing all medical functions within the company.

WittKieffer’s Stephen Brengle led this search.

Read the full announcement.